Argos Therapeutics Inc - Ordinary Shares

(ARGS)

By |

Profile

Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Contact Information

Website: www.argostherapeutics.com
Main Phone: +1 919 287-6300
Address: 4233 Technology Drive
State: NC
City / Town: Durham
Country: USA
Postal Code: 27704

Issuer Information

Exchange: OTCQB
CEO: Jeffrey D. Abbey
Employees: 39
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.12 $ 0.02 (20.00%)
Last Price 0.12 Change $ 0.02 Change % 20.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.0939 High 0.12 Low 0.0875 Prev Close 0.10
Last Trade Volume 16,996 52 Wk Hi 5.80 52 Wk Low 0.0751
Market Cap 1.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 10,586,661.00 EPS (TTM) 0.06 PE Ratio 1.70 Exchange OTCQB
  Last 3 Mo Last 12 Mo
Number of Insider Trades 8 22
Number of Buys 4 8
Number of Sells 4 14
Net Activity 0 837784
Last 10 Buys Shares
Sander van Deventer 1,000
Sander van Deventer 1,000
Sander van Deventer 1,000
Sander van Deventer 1,000
Hubert Birner 1,000
Hubert Birner 1,000
Sander van Deventer 1,000
Sander van Deventer 1,000
Hubert Birner 1,000
Hubert Birner 1,000
Last 10 Sell Shares
Richard D. Katz 1,000
Charles A. Nicolette 1,000
Lori R. Harrelson 1,000
Jeffrey D. Abbey 1,000
Jeffrey D. Abbey 1,000
Jeffrey D. Abbey 1,000
Jeffrey D. Abbey 1,000
Richard D. Katz 1,000
Charles A. Nicolette 1,000
Lori R. Harrelson 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 0.75 0.75 0.75 0.75
Low Target Price Estimate 0.75 0.75 0.75 0.75
Mean Target Price Estimate 0.75 0.75 0.75 0.75
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/09/17 08/09/17 08/09/17 08/09/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 3